Stay updated on Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page
- Check7 days agoChange DetectedA new revision label 'Revision: v3.5.5' was added to the history list, replacing the previous 'Revision: v3.5.4'. This represents a small site-build update reflected in the version history and does not change the underlying study records or user-facing content.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.5.4 appears in the page footer, replacing the previous v3.5.3. This indicates a small update to the site's revision tag within the Record History display.SummaryDifference0.0%

- Check43 days agoChange DetectedA new Completed status with Study Status and Recruitment Status entries was added, along with corresponding dates, and the prior Active, not recruiting status was removed. This documents that the trial has concluded and is no longer recruiting.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page’s displayed software/site revision was updated from v3.5.0 to v3.5.3, reflecting a minor ClinicalTrials.gov release rather than any change to the underlying study record.SummaryDifference0.0%

- Check86 days agoChange DetectedAdded a new Study Status entry to the record history in the latest revision (v3.5.0). The older Revision: v3.4.3 was removed (2025-08-29).SummaryDifference0.2%

- Check101 days agoChange DetectedAdded a new history entry: Revision: v3.4.3, and removed Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.